A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning

By Deshpande S.S.   Sheridan R.E.   Adler M.  

Toxicon, Vol. 33, Iss. 4, 1995-04 ,pp. : 551-557

Elsevier

Access to resources Recommend Favorite

Studies on the protective efficacy of recombinant truncated Hc from Clostridium botulinum neurotoxin A

By Smith L.   Zuber M.   Hoover T.  

Toxicon, Vol. 33, Iss. 3, 1995-03 ,pp. : 297-298

Elsevier

Access to resources Recommend Favorite

Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants

By Jensen M.J.   Smith T.J.   Ahmed S.A.   Smith L.A.  

Toxicon, Vol. 41, Iss. 6, 2003-05 ,pp. : 691-701

Elsevier

Access to resources Recommend Favorite

Development of recombinant vaccines for botulinum neurotoxin

By Smith L.A.  

Toxicon, Vol. 36, Iss. 11, 1998-11 ,pp. : 1539-1548

Elsevier

Access to resources Recommend Favorite

Pharmacological Profile of CEB-1957 and Atropine toward Brain Muscarinic Receptors and Comparative Study of Their Efficacy against Sarin Poisoning

By Trovero F.   Brochet D.   Breton P.   Tambute A.   Begos A.   Bizot J.-C.  

Toxicology and Applied Pharmacology, Vol. 150, Iss. 2, 1998-06 ,pp. : 321-327

Elsevier

Access to resources Recommend Favorite